1、Table of ContentsAs filed with the Securities and Exchange Commission on January 21,2022Registration Statement No.333 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933PARDES BIOSCIENCES,INC.(Exact Name of Registrant as Sp
2、ecified in Its Charter)Delaware 2834 85-2696306(State or Other Jurisdiction ofIncorporation or Organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification Number)2173 Salk Avenue,Suite 250PMB#052Carlsbad,CA 92008(415)649-8758(Address,including zip code,and telep
3、hone number,including area code,of Registrants principal executive offices)Uri A.Lopatin,M.D.President and Chief Executive Officer2173 Salk Avenue,Suite 250PMB#052Carlsbad,CA 92008(415)649-8758(Name,address,including zip code,and telephone number,including area code,of agent for service)Copies to:De
4、epa M.RichSam ZuckerJames XuGoodwin Procter LLP601 Marshall StreetRedwood City,CA 94063Approximate date of commencement of proposed sale to the public:From time to time after this Registration Statement becomes effective.If any of the securities being registered on this Form are to be offered on a d
5、elayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box:If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,please check the following box and list the Securities Act registrationstat
6、ement number of the earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule 462(c)under the Securities Act,check the following box and list the Securities Act registration statement number of theearlier effective registration s